10x Insights
Loading account…
Companies / Health Care / HeartBeam, Inc.
BEAT

HeartBeam, Inc.

Health CareSurgical & Medical Instruments
Ticker BEATSANTA CLARA, CAFiscal year ends DecemberBook value per share $0.18Diluted shares 46.7M

HeartBeam, Inc. (Nasdaq: BEAT) is a medical technology company developing ambulatory cardiac monitoring products for use outside healthcare facilities. Its HeartBeam System combines a credit-card-sized, cable-free device that records the heart’s electrical signals in three dimensions with software that synthesizes a… From the company’s description.

In fiscal 2025, HeartBeam, Inc. reported a net loss of $21.02M. Operations used $13.99M in cash.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
—
0.00%FY2025
$-21.02MFY2025
−8.1% year over year
Last 12 mo $-20.30M
-807.34%FY2025
+368.5 percentage points
Last 12 mo -248.21%
Cash & financing
$-13.99MFY2025
+3.3% year over year
Last 12 mo $-13.02M
$-14.59MFY2025
+0.6% year over year
Last 12 mo $-14.01M
—
33.7MFY2025
+26.5% year over year
Last 12 mo 46.7M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What HeartBeam, Inc. does

In the company’s own words

HeartBeam, Inc. (Nasdaq: BEAT) is a medical technology company developing ambulatory cardiac monitoring products for use outside healthcare facilities. Its HeartBeam System combines a credit-card-sized, cable-free device that records the heart’s electrical signals in three dimensions with software that synthesizes a 12-lead ECG, a patient application, a physician portal and cardiologist review services. The system is FDA-cleared for arrhythmia assessment, and its intended users include patients monitored by concierge and preventive cardiology practices, cardiologists and hospitals; insurers are also potential customers. HeartBeam is developing a 12-lead ECG extended-wear patch, heart-attack detection capabilities and AI-based diagnostic tools. It operates as one business, with no reportable segments described. The company had 16 employees as of December 31, 2025. Its system generated no revenue in 2025, while a limited market introduction was planned for early 2026.

Company details
Sector
Health Care
Industry (SIC)
Surgical & Medical Instruments
Headquarters
SANTA CLARA, CA
Fiscal year end
December
CIK
1779372
SIC
3841

Financial performance, year by year

Fiscal 2021–2025 · USD
$-22.67M$-17.70M$-12.72M$-7.75M$-2.77M20212022202320242025Last 12 moLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns HeartBeam, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

10
funds hold it
0 of 35
superinvestors hold it
$1.99M
held by funds, at market
4.6%
of shares held by funds

Largest fund holders · HeartBeam, Inc.’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.00%of fund net assets
Fidelity Extended Market Index Fund
FSMAX · Fidelity Concord Street Trust
—of fund net assets
iShares Micro-Cap ETF
IWC · iShares Trust
0.01%of fund net assets
Fidelity Series Total Market Index Fund
FCFMX · Fidelity Concord Street Trust
—of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Could not be determined for this company: bond issues.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do HeartBeam, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of HeartBeam, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in HeartBeam, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.